Clincosm LogoSign in Get a demo

esophagogastric adenocarcinoma

Showing 1 - 6 of 6
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Esophagogastric Adenocarcinoma Trial (Sacituzumab govitecan)

Not yet recruiting
  • Esophagogastric Adenocarcinoma
  • Sacituzumab govitecan
  • (no location specified)
Nov 9, 2023

Esophagogastric Adenocarcinoma Trial (Pembrolizumab, Trastuzumab, FLOT)

Not yet recruiting
  • Esophagogastric Adenocarcinoma
  • (no location specified)
Aug 17, 2022

Gastroesophageal Adenocarcinoma: A Prospective Feasibility Study

Recruiting
  • Esophagogastric Adenocarcinoma
  • Molecular Profiling
  • Toronto, Ontario, Canada
    University Health Network
Apr 27, 2021

Esophagogastric Adenocarcinoma Trial in United States (Nintedanib)

Completed
Has Results
  • Esophagogastric Adenocarcinoma
  • Basking Ridge, New Jersey
  • +5 more
Dec 30, 2020

Esophagogastric Adenocarcinoma Trial in New York (Crenolanib, Ramucirumab, Paclitaxel)

Completed
  • Esophagogastric Adenocarcinoma
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jul 17, 2020

Esophagogastric Adenocarcinoma, Metastatic Disease, No Previous Chemo for Metastatic Esophagogastric Cancer Trial (Nintedanib,

Withdrawn
  • Esophagogastric Adenocarcinoma
  • +2 more
  • (no location specified)
May 8, 2017